Jay D. Sherr

488 total citations
13 papers, 367 citations indexed

About

Jay D. Sherr is a scholar working on Psychiatry and Mental health, Molecular Biology and Pharmacology. According to data from OpenAlex, Jay D. Sherr has authored 13 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Jay D. Sherr's work include Schizophrenia research and treatment (6 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Neurological disorders and treatments (2 papers). Jay D. Sherr is often cited by papers focused on Schizophrenia research and treatment (6 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Neurological disorders and treatments (2 papers). Jay D. Sherr collaborates with scholars based in United States and Germany. Jay D. Sherr's co-authors include Gunvant K. Thaker, Matthew T. Avila, Carol S. Myers, Helene Adami, Teresa A. Blaxton, Shawn L. Cassady, Elliot Hong, David E. Ross, Deborah R. Medoff and Ikwunga Wonodi and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Jay D. Sherr

12 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay D. Sherr United States	9	178	129	71	69	51	13	367
EC Johnstone United Kingdom	10	141 0.8×	150 1.2×	60 0.8×	46 0.7×	37 0.7×	23	380
Céline Goldberger France	9	145 0.8×	59 0.5×	70 1.0×	74 1.1×	23 0.5×	19	335
Fred Ovsiew United States	10	122 0.7×	106 0.8×	72 1.0×	58 0.8×	16 0.3×	23	343
A.G. Cardno United Kingdom	14	244 1.4×	151 1.2×	120 1.7×	158 2.3×	24 0.5×	24	536
Concetta Petruzzi Italy	14	251 1.4×	56 0.4×	131 1.8×	51 0.7×	119 2.3×	23	565
Ricardo Dávila Spain	11	246 1.4×	33 0.3×	35 0.5×	80 1.2×	28 0.5×	29	416
Berko Milleit Germany	11	103 0.6×	100 0.8×	34 0.5×	43 0.6×	78 1.5×	14	357
Ermias Seleshi United States	9	208 1.2×	58 0.4×	30 0.4×	48 0.7×	64 1.3×	11	329
S. Silvestri Canada	7	243 1.4×	64 0.5×	59 0.8×	121 1.8×	17 0.3×	7	384
Elizabeth Hill United States	6	158 0.9×	52 0.4×	120 1.7×	27 0.4×	73 1.4×	9	346

Countries citing papers authored by Jay D. Sherr

Since Specialization

Citations

This map shows the geographic impact of Jay D. Sherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay D. Sherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay D. Sherr more than expected).

Fields of papers citing papers by Jay D. Sherr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay D. Sherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay D. Sherr. The network helps show where Jay D. Sherr may publish in the future.

Co-authorship network of co-authors of Jay D. Sherr

This figure shows the co-authorship network connecting the top 25 collaborators of Jay D. Sherr. A scholar is included among the top collaborators of Jay D. Sherr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay D. Sherr. Jay D. Sherr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Edwards, Natalie C., Jacqueline Pesa, Dennis Meletiche, et al.. (2008). One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia. Current Medical Research and Opinion. 24(12). 3341–3355. 26 indexed citations

Kramer, Michelle, Mariëlle Eerdekens, A. Schreiner, et al.. (2008). 341 – Oral paliperidone extended-release treatment: Long-term metabolic outcomes in patients with schizophrenia. Schizophrenia Research. 98. 173–174. 2 indexed citations

Kramer, Michelle, L. Hargarter, Stuart Kushner, et al.. (2007). Delaying symptom recurrence in patients with schizophrenia with paliperidone extended-release tablets: an international, randomized, double-blind, placebo-controlled study (PAL-SCH-301). Pharmacopsychiatry. 40(5). 5 indexed citations

Wonodi, Ikwunga, Helene Adami, Jay D. Sherr, et al.. (2004). Naltrexone Treatment of Tardive Dyskinesia in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 24(4). 441–445. 19 indexed citations

Wonodi, Ikwunga, Helene Adami, Shawn L. Cassady, et al.. (2004). Ethnicity and the Course of Tardive Dyskinesia in Outpatients Presenting to the Motor Disorders Clinic at the Maryland Psychiatric Research Center. Journal of Clinical Psychopharmacology. 24(6). 592–598. 34 indexed citations

Sherr, Jay D., et al.. (2003). Neurodevelopmental Interactions Conferring Risk for Schizophrenia: A Study of Dermatoglyphic Markers in Patients and Relatives. Schizophrenia Bulletin. 29(3). 595–605. 29 indexed citations

Avila, Matthew T., Jay D. Sherr, Elliot Hong, Carol S. Myers, & Gunvant K. Thaker. (2003). Effects of Nicotine on Leading Saccades during Smooth Pursuit Eye Movements in Smokers and Nonsmokers with Schizophrenia. Neuropsychopharmacology. 28(12). 2184–2191. 67 indexed citations

Sherr, Jay D., et al.. (2002). The effects of nicotine on specific eye tracking measures in schizophrenia. Biological Psychiatry. 52(7). 721–728. 74 indexed citations

Sherr, Jay D., Gunvant K. Thaker, & Carol A. Tamminga. (2002). The Prevention and Management of Tardive Dyskinesia in the Elderly. Psychiatric Annals. 32(4). 237–243. 3 indexed citations

10.

Thaker, Gunvant K., David E. Ross, Shawn L. Cassady, et al.. (2000). Saccadic eye movement abnormalities in relatives of patients with schizophrenia. Schizophrenia Research. 45(3). 235–244. 58 indexed citations

11.

Arango, Celso, Helene Adami, Jay D. Sherr, Gunvant K. Thaker, & William T. Carpenter. (1999). Relationship of Awareness of Dyskinesia in Schizophrenia to Insight Into Mental Illness. American Journal of Psychiatry. 156(7). 1097–1099. 34 indexed citations

12.

Sherr, Jay D., et al.. (1999). Neuroleptic Discontinuation and Tardive Dyskinesia Risk. American Journal of Psychiatry. 156(7). 1125–1125. 1 indexed citations

13.

Sherr, Jay D. & Deanna L. Kelly. (1998). Substitution of Immediate-Release Valproic Acid for Divalproex Sodium for Adult Psychiatric Inpatients. Psychiatric Services. 49(10). 1355–1357. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact